Education
About Us
Working with TipRanks
Follow Us
Kamada (KMDA)
NASDAQ:KMDA
Earnings Data
Report Date
May 27, 2025TBA Not Confirmed
Period Ending
2025 (Q1)Consensus EPS Forecast
0.07Last Year’s EPS
0.04Same Quarter Last Year
Strong Buy
Based on 3 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Mar 05, 2025
|% Change Since: 4.67%
|Next Earnings Date:May 27, 2025
Earnings Call Sentiment|Positive
Kamada delivered strong financial performance in 2024 with record revenues and adjusted EBITDA, supported by successful product launches and expansion of plasma collection centers. However, increased operating expenses and financial challenges in Q4 2024 were noted. The company's positive outlook for 2025, including expected revenue and EBITDA growth, and the declaration of a special dividend, indicate confidence in future performance.Company Guidance
During the Kamada Fourth Quarter and Full Year 2024 Earnings Conference Call, the company provided a robust financial outlook for 2025. Kamada reported record revenues of $161 million for 2024, marking a 13% increase from 2023, and an adjusted EBITDA of $34.1 million, reflecting a 42% year-over-year growth. These results were driven by strong sales of KEDRAB and CYTOGAM. The company generated $47.6 million in cash from operations, leading to a solid year-end cash position of $78.4 million, enabling the declaration of a $0.20 per share special cash dividend. For 2025, Kamada forecasts revenues between $178 million and $182 million and an adjusted EBITDA ranging from $38 million to $42 million, anticipating a revenue increase of approximately 12% and a 17% rise in adjusted EBITDA over 2024. The company plans to continue its growth trajectory through the expansion of its commercial portfolio, business development, M&A activities, and advancements in its plasma collection operations and ongoing Phase 3 pivotal trial for an inhaled AAT product targeting a $2 billion market.Record-Breaking Revenue and Growth in 2024
Total revenue for 2024 was $161 million, representing a 13% increase over 2023 revenues. Adjusted EBITDA was a record $34.1 million, representing a 42% year-over-year growth.
Strong Financial Position and Special Dividend
Generated $47.6 million in cash from operations in 2024, resulting in a year-end strong balance sheet with $78.4 billion in cash. Announced a special cash dividend of $0.20 per share.
Positive Outlook for 2025
Forecasting 2025 annual revenues of $178 million to $182 million and $38 million to $42 million of adjusted EBITDA, representing an increase of approximately 12% in revenues and 17% in adjusted EBITDA over 2024.
Expansion of Plasma Collection Centers
Opened second plasma collection center in Houston, Texas, and completed construction of a third in San Antonio, Texas, expected to contribute $8 million to $10 million in sales of normal source plasma annually.
Successful Product Launches and Contracts
Launched first biosimilar product in Israel and awarded a three-year contract for the supply of KAMRAB and VARIZIG in Latin America, expected to generate approximately $25 million in revenue.
---
KMDA Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
KMDA Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Mar 05, 2025 | $6.42 | $6.90 | +7.48% |
| Nov 13, 2024 | $6.10 | $5.86 | -3.93% |
| Aug 14, 2024 | $5.40 | $5.18 | -4.07% |
| May 08, 2024 | $5.45 | $5.58 | +2.39% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Kamada (KMDA) report earnings?
Kamada (KMDA) is schdueled to report earning on May 27, 2025, TBA Not Confirmed.
What is Kamada (KMDA) earnings time?
Kamada (KMDA) earnings time is at May 27, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is KMDA EPS forecast?
KMDA EPS forecast for the fiscal quarter 2025 (Q1) is 0.07.
---